Literature DB >> 26392539

The membrane anchor of the transcriptional activator SREBP is characterized by intrinsic conformational flexibility.

Rasmus Linser1, Nicola Salvi2, Rodolfo Briones3, Petra Rovó4, Bert L de Groot3, Gerhard Wagner5.   

Abstract

Regulated intramembrane proteolysis (RIP) is a conserved mechanism crucial for numerous cellular processes, including signaling, transcriptional regulation, axon guidance, cell adhesion, cellular stress responses, and transmembrane protein fragment degradation. Importantly, it is relevant in various diseases including Alzheimer's disease, cardiovascular diseases, and cancers. Even though a number of structures of different intramembrane proteases have been solved recently, fundamental questions concerning mechanistic underpinnings of RIP and therapeutic interventions remain. In particular, this includes substrate recognition, what properties render a given substrate amenable for RIP, and how the lipid environment affects the substrate cleavage. Members of the sterol regulatory element-binding protein (SREBP) family of transcription factors are critical regulators of genes involved in cholesterol/lipid homeostasis. After site-1 protease cleavage of the inactive SREBP transmembrane precursor protein, RIP of the anchor intermediate by site-2 protease generates the mature transcription factor. In this work, we have investigated the labile anchor intermediate of SREBP-1 using NMR spectroscopy. Surprisingly, NMR chemical shifts, site-resolved solvent exposure, and relaxation studies show that the cleavage site of the lipid-signaling protein intermediate bears rigid α-helical topology. An evolutionary conserved motif, by contrast, interrupts the secondary structure ∼9-10 residues C-terminal of the scissile bond and acts as an inducer of conformational flexibility within the carboxyl-terminal transmembrane region. These results are consistent with molecular dynamics simulations. Topology, stability, and site-resolved dynamics data suggest that the cleavage of the α-helical substrate in the case of RIP may be associated with a hinge motion triggered by the molecular environment.

Entities:  

Keywords:  SREBP; cancer; cellular lipid homeostasis; membrane proteins; regulated intramembrane proteolysis

Mesh:

Substances:

Year:  2015        PMID: 26392539      PMCID: PMC4603520          DOI: 10.1073/pnas.1513782112

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  44 in total

Review 1.  Update 1 of: Proteases universally recognize beta strands in their active sites.

Authors:  Praveen K Madala; Joel D A Tyndall; Tessa Nall; David P Fairlie
Journal:  Chem Rev       Date:  2010-04-08       Impact factor: 60.622

Review 2.  Regulated intramembrane proteolysis: signaling pathways and biological functions.

Authors:  Mark Lal; Michael Caplan
Journal:  Physiology (Bethesda)       Date:  2011-02

3.  Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment.

Authors:  J Sakai; E A Duncan; R B Rawson; X Hua; M S Brown; J L Goldstein
Journal:  Cell       Date:  1996-06-28       Impact factor: 41.582

Review 4.  The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.

Authors:  M S Brown; J L Goldstein
Journal:  Cell       Date:  1997-05-02       Impact factor: 41.582

Review 5.  Sterol regulatory element binding proteins (SREBPs): controllers of lipid synthesis and cellular uptake.

Authors:  M S Brown; J L Goldstein
Journal:  Nutr Rev       Date:  1998-02       Impact factor: 7.110

Review 6.  Increased lipogenesis in cancer cells: new players, novel targets.

Authors:  Johannes V Swinnen; Koen Brusselmans; Guido Verhoeven
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2006-07       Impact factor: 4.294

Review 7.  SREBP transcription factors: master regulators of lipid homeostasis.

Authors:  Delphine Eberlé; Bronwyn Hegarty; Pascale Bossard; Pascal Ferré; Fabienne Foufelle
Journal:  Biochimie       Date:  2004-11       Impact factor: 4.079

8.  Topology of SREBP cleavage-activating protein, a polytopic membrane protein with a sterol-sensing domain.

Authors:  A Nohturfft; M S Brown; J L Goldstein
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

9.  Backbone dynamics of proteins as studied by 15N inverse detected heteronuclear NMR spectroscopy: application to staphylococcal nuclease.

Authors:  L E Kay; D A Torchia; A Bax
Journal:  Biochemistry       Date:  1989-11-14       Impact factor: 3.162

10.  Co-crystal structure of sterol regulatory element binding protein 1a at 2.3 A resolution.

Authors:  A Párraga; L Bellsolell; A R Ferré-D'Amaré; S K Burley
Journal:  Structure       Date:  1998-05-15       Impact factor: 5.006

View more
  4 in total

1.  Modulating Hinge Flexibility in the APP Transmembrane Domain Alters γ-Secretase Cleavage.

Authors:  Alexander Götz; Nadine Mylonas; Philipp Högel; Mara Silber; Hannes Heinel; Simon Menig; Alexander Vogel; Hannes Feyrer; Daniel Huster; Burkhard Luy; Dieter Langosch; Christina Scharnagl; Claudia Muhle-Goll; Frits Kamp; Harald Steiner
Journal:  Biophys J       Date:  2019-05-03       Impact factor: 4.033

2.  Site-1 protease-derived soluble (pro)renin receptor targets vasopressin receptor 2 to enhance urine concentrating capability.

Authors:  Fei Wang; Chuanming Xu; Renfei Luo; Kexin Peng; Nirupama Ramkumar; Shiying Xie; Xiaohan Lu; Long Zhao; Chang-Jiang Zuo; Donald E Kohan; Tianxin Yang
Journal:  JCI Insight       Date:  2019-04-04

3.  Dissecting conformational changes in APP's transmembrane domain linked to ε-efficiency in familial Alzheimer's disease.

Authors:  Alexander Götz; Christina Scharnagl
Journal:  PLoS One       Date:  2018-07-02       Impact factor: 3.240

4.  Site-1 Protease-Derived Soluble (Pro)Renin Receptor Contributes to Angiotensin II-Induced Hypertension in Mice.

Authors:  Ye Feng; Kexin Peng; Renfei Luo; Fei Wang; Tianxin Yang
Journal:  Hypertension       Date:  2020-12-07       Impact factor: 9.897

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.